Capturing opportunities in the CLO market requires a combination of taking an active approach and the need for a dedicated an experienced team of managers. The requirement for an active approach is particularly important given the additional nuances of investing in the securitised market over and above conventional fixed income.

Please watch the first installment in our CLO Essentials Webcast series, 'Active ETFs: Why and why now?' which took place on Monday 31 March.

Please watch Dan Lyons, Portfolio Manager on the Health Care and Biotech Teams, give an update on the Global Life Sciences strategy, as well as sharing his latest market perspectives and outlook.